Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Herlyn

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Experimental and Clinical Immunogenetics|January 1, 1988
Functional mimicry of tumor-associated antigens by antiidiotypic antibodiesD Herlyn, M Wettendorff, D Iliopoulos, et al.
European Journal of Immunology|August 1, 1979
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinomaD Herlyn, M Herlyn, Z Steplewski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Study of antibodies against human melanoma produced by somatic cell hybridsH Koprowski, Z Steplewski, D Herlyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodiesM Herlyn, Z Steplewski, D Herlyn, et al.
International Reviews of Immunology|January 1, 1991
Epitope- and antigen-specific cancer vaccinesD Herlyn, A Linnenbach, H Koprowski, et al.
Cell Biophysics|August 1, 1995
Animal models of human-derived cancer vaccinesD Herlyn, R Somasundaram, W Li, et al.
Cellular Immunology|April 15, 1985
Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cellsD Herlyn, M Herlyn, Z Steplewski, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1996
Anti-idiotype cancer vaccines: past and futureD Herlyn, R Somasundaram, W Li, et al.
Molecular Immunology|December 1, 1989
Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylationR J Rothman, B Perussia, D Herlyn, et al.
Cancer Research|November 1, 1985
Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinomaH F Sears, D Herlyn, Z Steplewski, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Experimental and Clinical Immunogenetics|January 1, 1988
Functional mimicry of tumor-associated antigens by antiidiotypic antibodiesD Herlyn, M Wettendorff, D Iliopoulos, et al.
European Journal of Immunology|August 1, 1979
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinomaD Herlyn, M Herlyn, Z Steplewski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1978
Study of antibodies against human melanoma produced by somatic cell hybridsH Koprowski, Z Steplewski, D Herlyn, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodiesM Herlyn, Z Steplewski, D Herlyn, et al.
International Reviews of Immunology|January 1, 1991
Epitope- and antigen-specific cancer vaccinesD Herlyn, A Linnenbach, H Koprowski, et al.
Cell Biophysics|August 1, 1995
Animal models of human-derived cancer vaccinesD Herlyn, R Somasundaram, W Li, et al.
Cellular Immunology|April 15, 1985
Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cellsD Herlyn, M Herlyn, Z Steplewski, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1996
Anti-idiotype cancer vaccines: past and futureD Herlyn, R Somasundaram, W Li, et al.
Molecular Immunology|December 1, 1989
Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylationR J Rothman, B Perussia, D Herlyn, et al.
Cancer Research|November 1, 1985
Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinomaH F Sears, D Herlyn, Z Steplewski, et al.
Pageof 11